| galantamine hydrobromide / Generic mfg. |
NCT00035204: A Study of the Effects on Sleep, Attention, and Gastrointestinal Tolerance of Galantamine and Donepezil in Patients With Alzheimer's Disease |
|
|
| Completed | 4 | 63 | US | galantamine | Johnson & Johnson Pharmaceutical Research & Development, L.L.C., Ortho-McNeil Neurologics, Inc. | Alzheimer Disease | | 05/03 | | |
NCT00227994: Acetylcholinesterase Inhibitors to Improve Cognitive Function and Overall Rehabilitation After a Stroke |
|
|
| Completed | 4 | 40 | US | Galantamine, Razadyne, Donepezil, Aricept | University of Pittsburgh, National Institute of Mental Health (NIMH) | Cerebrovascular Accident | 01/05 | 03/05 | | |
NCT00234637: Rivastigmine Monotherapy and Combination Therapy With Memantine in Patients With Moderately Severe Alzheimer's Disease Who Failed to Benefit From Previous Cholinesterase Inhibitor Treatment |
|
|
| Completed | 4 | 204 | Europe | Rivastigmine, memantine | Novartis | Alzheimer's Disease | 06/05 | 06/05 | | |
NCT00216515: The Efficacy of Galantamine on the Attention and the Frontal Function of the Patients With Dementia of Alzheimer Type |
|
|
| Completed | 4 | 102 | RoW | galantamine hydrobromide | Janssen Korea, Ltd., Korea | Alzheimer Disease | | 11/05 | | |
| Terminated | 4 | 1 | US | galantamine | Parkinson's Disease and Movement Disorders Center, Ortho-McNeil Neurologics, Inc. | Tourette's Syndrome, Motor Tic Disorder, Vocal Tic Disorder | | 05/07 | | |
NCT01921972: The Efficacy of a Combination Regimen in Patients With Mild to Moderate Probable Alzheimer's Disease |
|
|
| Completed | 4 | 232 | Europe | Galantamine CR, Memantine, Placebo | Charite University, Berlin, Germany, German Federal Ministry of Education and Research | Alzheimer's Disease | 11/08 | 05/09 | | |
NCT01054976: The Efficacy of Galantamine Treatment on Attention in Patients With Alzheimer's Disease |
|
|
| Completed | 4 | 99 | RoW | Galantamine | Janssen Korea, Ltd., Korea | Alzheimer's Disease | 02/09 | 02/09 | | |
| Terminated | 4 | 1 | Europe | Galantamine | Janssen-Cilag, S.A. | Alzheimer Disease | 06/11 | 06/11 | | |
NCT01478633: Evaluation of Efficacy and Safety of Galantamine in Patients With Dementia of Alzheimer's Type Who Failed to Benefit From Donepezil |
|
|
| Completed | 4 | 102 | Japan | Galantamine | Janssen Pharmaceutical K.K. | Alzheimer's Disease | 06/13 | 06/13 | | |
NCT01529619: Efficacy, Safety and Tolerability of Rivastigmine Patch in Patients With Mild to Moderate Alzheimer's Disease Switched From Cholinesterase Inhibitors |
|
|
| Completed | 4 | 52 | Japan | Rivastigmine transdermal patch | Novartis Pharmaceuticals, Ono Pharmaceutical Co. Ltd | Alzheimer's Disease | 12/13 | 12/13 | | |
